FINWIRES · TerminalLIVE
FINWIRES

Transwarp Technology Nets HK$686.5 Million in Hong Kong IPO

By

Transwarp Technology (Shanghai) (HKG:6727, SHA:688031) is set to receive HK$686.5 million in net proceeds from its initial public offering in Hong Kong after pricing shares within the previously provided price band.

The enterprise AI software company priced 14 million H-shares at HK$49 apiece, which is at the low end of its guidance range of up to HK$61, according to a Friday bourse filing.

The Hong Kong public offering was 73.86 times subscribed, with 2.8 million shares allocated, while the international offering was 1.42 times subscribed, with 11.2 million shares allocated.

Cornerstone investors were allotted 1.5 million shares, representing 10.75% of the IPO shares.

Transwarp is set to debut on the Hong Kong bourse on Monday, Sept. 21.

What else is happening in Asia?

Asia

Newlink Technology's Potential Acquisition of HK Ant Global Investment Falls Through

Newlink Technology (HKG:9600) terminated a memorandum of intent for the potential acquisition of HK Ant Global Investment.The parties had entered the memorandum in May, a Friday bourse filing showed.

HKG:9600
Asia

New Concepts Raises HK$4.9 Million from Share Issue

New Concepts Holdings (HKG:2221) completed the issue of 5 million new shares to Du Lei to raise net proceeds of nearly HK$4.9 million.The parties had entered into the share subscription agreement earlier in September, a Friday bourse filing showed.The construction company plans to use proceeds for general working capital.

HKG:2221
Asia

Eternity Investment Unit, Director Dispose Of Stake in China Healthwise

Eternity Investment (HKG:0764) unit Eternity Finance and executive director Lei Hong Wai agreed to sell around 169 million and 18.7 million respective shares in China Healthwise (HKG:0348).The shares, representing an 18.3% and 2% stake in China Healthwise, respectively, were sold to Hwa Sheng International Investment at HK$0.08 apiece, a Friday bourse filing showed.The company will receive a consideration of around HK$13.5 million from the disposal and cease to hold any stake in China Healthwise following completion.Proceeds will be used to repay a margin loan, as well as for general working capital.

HKG:0348HKG:0764